Abstract

Case Report

Cervical choriocarcinoma in a post-menopause woman: Case report and review of literature

Zeinab Nazari, Leila Mortazavi* and Noushin Gordani

Published: 31 January, 2022 | Volume 5 - Issue 1 | Pages: 019-021

Background: Cervical choriocarcinoma is a malignant trophoblastic neoplasm that arises from pluripotent gonadal germ cells. Various manifestations are expected including vaginal bleeding and symptoms related to metastasis. Here, we report a case of primary choriocarcinoma in a post-menopausal woman. 
Case presentation: A 67-year-old woman presented with vaginal bleeding and lower abdominal pain. Ultrasound and laboratory results were normal except for a β-hCG titer of 14850 IU/L. Hysteroscopy revealed a polyp in the posterior wall of the cervix. hysterectomy and bilateral salpingo-oophorectomy were performed due to suspected choriocarcinoma. The β-hCG titer decreased immediately after surgery. However, the β-hCG titer increased again one month after surgery and treatment was continued with weekly methotrexate administration. 
Conclusion: Manifestations such as vaginal bleeding is very important in post-menopausal women. Although there are no specific guidelines for the treatment of choriocarcinoma in these patients, hysterectomy following chemotherapy based on response to treatment and β-hCG titration is favorable.

Read Full Article HTML DOI: 10.29328/journal.cjog.1001101 Cite this Article Read Full Article PDF

Keywords:

Choriocarcinoma; Cervical polyp; Cervical neoplasm; Post-menopause

References

  1. Mangla M, Singla D, Kaur H, Sharma S. Unusual clinical presentations of choriocarcinoma: A systematic review of case reports. Taiwan J Obstet Gynecol. 2017; 56: 1-8. PubMed: https://pubmed.ncbi.nlm.nih.gov/28254207/
  2. Joshi SM, Das T, Dagar M, Srivastava M, Ganguli I, et al. A Rare Case of Choriocarcinoma. IJOPARB. 2020: 33.
  3. Stockton L, Green E, Kaur B, De Winton E. Non-gestational choriocarcinoma with widespread metastases presenting with type 1 respiratory failure in a 39-year-old female: case report and review of the literature. Case Rep Oncol. 2018; 11: 151-158. PubMed: https://pubmed.ncbi.nlm.nih.gov/29681814/
  4. Sorbi F, Sisti G, Pieralli A, Di Tommaso M, Livi L, et al. Cervicoisthmic choriocarcinoma mimicking cesarean section scar ectopic pregnancy. J Res Med Sci. 2013; 18: 914-917. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897080/
  5. Desai NR, Gupta S, Said R, Desai P, Dai Q. Choriocarcinoma in a 73-year-old woman: a case report and review of the literature. J Med Case Rep. 2010; 4: 379. PubMed: https://pubmed.ncbi.nlm.nih.gov/21108779/
  6. Guo N, Yin R, Li Q, Song L, Wang D. Postmenopausal choriocarcinoma: a rare case report and review of the literature. Menopause. 2018; 25: 239-241. PubMed: https://pubmed.ncbi.nlm.nih.gov/28816932/
  7. Lazare C, Zhi W, Dai J, Cao C, Sookha RR, et al. A pilot study comparing the genetic molecular biology of gestational and non-gestational choriocarcinoma. Am J Transl Res. 2019; 11: 7049-7062. PubMed: https://pubmed.ncbi.nlm.nih.gov/31814908/
  8. Balagopal P, Pandey M, Chandramohan K, Somanathan T, Kumar A. Unusual presentation of choriocarcinoma. World J Surg Oncol. 2003; 1: 1-4. PubMed: https://pubmed.ncbi.nlm.nih.gov/12773221/
  9. Chandacham A, Kietpeerakool C, Khunamornpong S, Suprasert P, Srisomboon J, et al. Successfully conservative treatment of large cervical choriocarcinoma with profuse vaginal bleeding. J Med Assoc Thai. 2009; 92: 120-123. PubMed: https://pubmed.ncbi.nlm.nih.gov/19260253/
  10. Tsujioka H, Hamada H, Miyakawa T, Hachisuga T, Kawarabayashi T. A pure nongestational choriocarcinoma of the ovary diagnosed with DNA polymorphism analysis. Gynecol Oncol. 2003; 89: 540-542. PubMed: https://pubmed.ncbi.nlm.nih.gov/12798727/
  11. Doll KM, Soper JT. The role of surgery in the management of gestational trophoblastic neoplasia. Obstet Gynecol Surv. 2013; 68: 533-542. PubMed: https://pubmed.ncbi.nlm.nih.gov/23803756/
  12. Goldfarb JA, Dinoi G, Mariani A, Langstraat CL. A case of multi-agent drug resistant choriocarcinoma treated with Pembrolizumab. Gynecol Oncol Rep. 2020; 32: 100574. PubMed: https://pubmed.ncbi.nlm.nih.gov/32395603/

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More